Justin Alan Fried, MD - CUIMC/Vivian & Seymour Milstein Family Heart Center

The Interventional Cardiologists in New York, NY are affiliated with Columbia University Irving Medical Center and provide cutting-edge cardiovascular care at the CUIMC Vivian Seymour Milstein Family Heart Center. Led by Dr. Mathew Maurer, these highly skilled cardiologists are part of the NewYork-Presbyterian ColumbiaDoctors network and are dedicated to advancing research and training in the field of interventional cardiology.Generated from the website

Robert Fee, PhD is a lifespan neuropsychologist who specializes in the evaluation of cognitive, behavioral, and emotional functioning in children. Dr. Fee earned his undergraduate degree at Louisiana State University, Masters from Columbia University, and his doctorate from City University of New York with a specialization in Clinical Neuropsychology. He completed his internship training in lifespan neuropsychology including pediatrics, epilepsy, aging, movement disorders, stroke, and neurorehabilitation in the Department of Neurology at North Shore University Hospital as well as psychotherapy within the Department of Psychiatry at Zucker-Hillside Hospital (Northwell Health System). His postdoctoral training in Neuropsychology was completed at Columbia University Irving Medical Center within the Department of Neurology, Division of Cognitive Neuroscience and Division of Child Neurology, receiving advanced training in the assessment of individuals across the lifespan with various neurological disorders. His clinical activities focus on the assessment of children with neurodevelopmental disorders including intellectual disability, learning disorders, ADHD, autism spectrum disorder, motor disorders, language disorders, genetic disorders, as well as congenital and acquired brain injuries, epilepsy, neuromuscular disorders, neuro-oncology and other neurological conditions. He also provides psychotherapeutic consultation to children and families.

Monica Bhatia, MD specializes in the care of children with noncancerous blood disorders who may benefit from bone marrow transplantation, especially sickle cell anemia. She and her colleagues are working to reduce the toxicity (side effects) and complications of this treatment without compromising its effectiveness, and to make it available to more patients. The field of pediatric hematology brings with it many intellectual challenges, and bone marrow transplantation in particular is especially dynamic. Dr. Bhatia has the opportunity to provide care for the sickest children, potentially curing their disease. She builds strong relationships with her patients and their families that last for years. It is inspiring for her to see young patients grow up to lead healthy, productive lives. NewYork-Presbyterian/Morgan Stanley Children's Hospital has a robust program for bone marrow transplantation for sickle cell anemia - the only cure for this disease. Dr. Bhatia and her team have witnessed remarkable results among children who are cured with bone marrow transplantation and spared from the potentially life-threatening complications of sickle cell disease. Yet despite the advances made, only 15 percent of patients with sickle cell disease have a matched sibling bone marrow donor. Therefore, Dr. Bhatia and her team conduct research to evaluate a procedure called "CD34-selected stem cell transplantation" to remove T-cells from donor bone marrow for patients without a matched sibling donor. This approach reduces the risk of graft-versus-host disease (GVHD), a potential complication of bone marrow transplantation in which T-cells from the donor attack the tissue of the recipient. This approach to harnessing stem cells could potentially make bone marrow transplantation a safer, effective option for many patients who are seeking a cure for sickle cell disease. Dr. Bhatia and her colleagues are currently assessing reduced-intensity transplantation, which uses lower doses of chemotherapy to decrease the risk of side effects and long-term complications without lowering the effectiveness of treatment. She is also interested in looking for ways to further improve the quality of life of patients who have had a bone marrow transplant in addition to fertility preservation.